Arteris, Inc. (NASDAQ:AIP – Get Free Report) CEO K Charles Janac sold 125,976 shares of the company’s stock in a transaction that occurred on Monday, July 6th. The stock was sold at an average price of $35.79, for a total value of $4,508,681.04. Following the transaction, the chief executive officer directly owned 8,429,071 shares in the company, valued at approximately $301,676,451.09. This trade represents a 1.47% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.
K Charles Janac also recently made the following trade(s):
- On Monday, July 6th, K Charles Janac sold 10,679 shares of Arteris stock. The shares were sold at an average price of $35.90, for a total value of $383,376.10.
- On Thursday, July 2nd, K Charles Janac sold 192,686 shares of Arteris stock. The shares were sold at an average price of $36.32, for a total value of $6,998,355.52.
- On Thursday, July 2nd, K Charles Janac sold 10,902 shares of Arteris stock. The stock was sold at an average price of $38.78, for a total value of $422,779.56.
- On Monday, June 8th, K Charles Janac sold 70,000 shares of Arteris stock. The stock was sold at an average price of $34.91, for a total value of $2,443,700.00.
- On Friday, May 8th, K Charles Janac sold 70,000 shares of Arteris stock. The shares were sold at an average price of $31.20, for a total transaction of $2,184,000.00.
Arteris Stock Up 10.0%
AIP stock traded up $3.14 during midday trading on Wednesday, reaching $34.46. 1,084,650 shares of the company’s stock traded hands, compared to its average volume of 755,391. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.17. The firm’s fifty day moving average price is $36.62 and its 200-day moving average price is $23.79. Arteris, Inc. has a 52 week low of $8.42 and a 52 week high of $50.26. The company has a market cap of $1.59 billion, a price-to-earnings ratio of -43.62 and a beta of 1.92.
Hedge Funds Weigh In On Arteris
Several institutional investors have recently added to or reduced their stakes in AIP. AQR Capital Management LLC bought a new stake in Arteris in the first quarter worth about $1,621,000. Strs Ohio bought a new position in shares of Arteris during the 1st quarter valued at approximately $104,000. Geode Capital Management LLC increased its stake in shares of Arteris by 4.8% during the 2nd quarter. Geode Capital Management LLC now owns 652,754 shares of the company’s stock worth $6,222,000 after purchasing an additional 30,018 shares during the last quarter. Rhumbline Advisers increased its stake in shares of Arteris by 35.8% during the 2nd quarter. Rhumbline Advisers now owns 54,416 shares of the company’s stock worth $519,000 after purchasing an additional 14,350 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership raised its holdings in shares of Arteris by 8.6% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 320,332 shares of the company’s stock worth $3,053,000 after purchasing an additional 25,448 shares during the period. Institutional investors own 64.36% of the company’s stock.
Analysts Set New Price Targets
AIP has been the subject of several analyst reports. Wall Street Zen downgraded Arteris from a “buy” rating to a “hold” rating in a research note on Saturday, May 2nd. Northland Securities set a $38.00 price target on Arteris in a report on Wednesday, May 13th. Jefferies Financial Group raised their price objective on Arteris from $16.00 to $35.00 and gave the company a “hold” rating in a research note on Wednesday, May 13th. TD Cowen lifted their price objective on shares of Arteris from $22.00 to $40.00 and gave the stock a “buy” rating in a report on Wednesday, May 13th. Finally, Rosenblatt Securities upped their target price on shares of Arteris from $20.00 to $38.00 and gave the stock a “buy” rating in a research note on Wednesday, May 13th. Two analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $37.75.
Check Out Our Latest Research Report on AIP
About Arteris
Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.
Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.
Recommended Stories
- Five stocks we like better than Arteris
- A Market Panic Just Discounted the AI Highway’s Tollbooth
- Why Exxon Could Be the Market’s Next Big Comeback Stock
- The Market Just Got Shaken—These 3 ETFs May Come Out Stronger
- Meta Platforms’ Cloud Push: Growth Opportunity Versus AI Concerns
Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.
